Glaukos
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 3 days.
- Recent price momentum is +88.8% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 7.6% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2849 U.S. stocks StockVane covers.
Last computed: 2026-11-21 08:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation F
How expensive the stock is versus earnings, sales and its own 5-year history.
| Forward P/E | 209.6x | Better than 1% |
| Price / Sales | 21.1x | Better than 6% |
Growth A
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 21.5% | Better than 83% |
| Net income CAGR (3Y) | 50.5% | Better than 88% |
Profitability D+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 55.7% | Better than 70% |
| Operating margin | -39.3% | Better than 10% |
| Net margin | -37.0% | Better than 10% |
| Return on equity | -26.4% | Better than 14% |
| Return on invested capital | -23.7% | Better than 12% |
Momentum A+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 28.4% | Better than 98% |
| 6-month return | 97.4% | Better than 99% |
| 12-month return (ex latest month) | 77.4% | Better than 92% |
| Distance below 52-week high | 7.0% | Better than 91% |
Financial Health B
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 4.7x | Better than 85% |
| Debt to assets | 11.6% | Better than 67% |
| Interest coverage | -40.6x | Better than 8% |
| Free cash flow / net income | 133.4% | Better than 59% |
Analyst View C+
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 90.9% | Better than 73% |
| Upside to average target | 0.2% | Better than 4% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 238.10
- Open
- 238.87
- Day range
- 233.40 - 244.55
- Avg price
- 237.52
- Volume
- 1.09M
- Turnover
- 258.79M
- Turnover ratei
- 1.91%
- Volume ratioi
- 1.35
- Amplitudei
- 4.68%
- 52-week rangei
- 93.96 - 255.19
Valuation
- P/Ei
- -72.35
- P/E (TTM)i
- -80.44
- P/Bi
- 19.58
- EPSi
- -3.28
- Book value / shi
- 12.12
- Net profit
- -194.17M
- Net assets
- 717.29M
Share structure
- Market cap
- 14.05B
- Float capi
- 13.54B
- Shares out
- 59.20M
- Float sharesi
- 57.07M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2015-06-25
7.0% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+25.06M net over the window
Short interest
- Shares short
- 4.48M
- % of floati
- 7.57%
- Days to coveri
- 2.85
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Glaukos (GKOS)?
Glaukos last traded at 237.31. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Glaukos's market cap?
About 14.05B.
What is the P/E ratio of Glaukos?
The trailing twelve-month P/E is -80.44. The Valuation tab shows it against the stock's own five-year range.
Does Glaukos pay a dividend?
Glaukos does not currently pay a regular dividend.
Is Glaukos a buy according to analysts?
The consensus of 11 analysts is a Buy rating, with an average 12-month price target of 237.82, which implies 0.2% upside from the current price. This is not investment advice.
What is Glaukos's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Glaukos a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 20:02:19 · For reference only, not investment advice and not tailored to your situation.
Glaukos discussion 0 comments